معرفی
Dr. Yiping Chen is a Senior Research Fellow at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), University of Oxford, affiliated with the Nuffield Department of Population Health. She leads the China Kadoorie Biobank (CKB) project involving 500,000 participants, focusing on clinical event validation and disease adjudication. Her research emphasizes cardiovascular diseases, mental health (major depression), sleep disorders, and environmental health impacts. She previously coordinated large clinical trials like COMMIT/CCS2 and SHARP, and ran the Oxford-China Fellowship programs for training epidemiologists.
Education: MBBS (Shanghai Medical University, 1985), DPhil (University of Oxford, 1993). Key roles include study coordination for multinational trials and directing CKB's validation protocols. Research spans proteomics, genetic epidemiology, and large-scale cohort studies addressing chronic diseases and environmental exposures.
Publications reflect her expertise in environmental health (air pollution effects), genetic studies (proteomic associations with stroke/cardiovascular disease), and lifestyle impacts on mortality. Her work integrates biostatistical methods with clinical validation processes. Awards: None explicitly stated. Advising: Leads CKB multidisciplinary teams and trained clinicians through fellowship programs. Labs/Teams: CKB, CTSU clinical trial units, and Oxford-China collaborations.
